Title:
ヒトインテグリンα４β７の阻害
Document Type and Number:
Japanese Patent JP7209116
Kind Code:
B2
Abstract:
Disclosed are small molecule antagonists of human α4β7 integrin, and methods of using them to treat a number of diseases and conditions.
Inventors:
Bersavich, Matthew G.
Cui, Dan
Dowling, James E.
Hahn, Christopher N.
Harrison, Bryce A.
Lin, Fu-Yang
Rippa, Blaze S.
Rogers, Bruce N.
Troast, Dawn M.
Zhong, Chen
Conz, Kyle Dee.
Gelashute, Alexie Ai.
Kim, Byangchan
Rafi, Salma
day, taylor
Hicky, Eugene
Howan, Evelyn
Saurer, Robert
Cui, Dan
Dowling, James E.
Hahn, Christopher N.
Harrison, Bryce A.
Lin, Fu-Yang
Rippa, Blaze S.
Rogers, Bruce N.
Troast, Dawn M.
Zhong, Chen
Conz, Kyle Dee.
Gelashute, Alexie Ai.
Kim, Byangchan
Rafi, Salma
day, taylor
Hicky, Eugene
Howan, Evelyn
Saurer, Robert
Application Number:
JP2021576053A
Publication Date:
January 19, 2023
Filing Date:
October 15, 2021
Export Citation:
Assignee:
Morphic Therapeutics, Incorporated
International Classes:
A61K31/4412; A61K31/4427; C07D213/64; C07D401/06
Domestic Patent References:
| JP2001524465A |
Foreign References:
| WO2019200202A1 | ||||
| US20030199692 | ||||
| WO2021076890A1 |
Attorney, Agent or Firm:
Patent Attorney Corporation Hiraki International Patent Office